Hypertrophic Cardiomyopathy: EP Considerations-ICD in Primary Prevention of SCD: Device and Programming Considerations (Presenter: Raul Weiss, MD, FHRS)

ICD in Primary Prevention of SCD: Device and Programming Considerations (Presenter: Raul Weiss, MD, FHRS)

Video Transcription

Video Summary

The video transcript discusses how to choose and program devices for patients with hypertrophic myopathy. It highlights that fibrillators are crucial in preventing sudden cardiac death in these patients, and that factors such as the patient's age, lifestyle, device longevity, need for pacing, and changes in EKG over time should be considered when selecting a device. The use of transvenous and subcutaneous defibrillators is discussed, with studies showing similar fibrillation energy requirements and safety margins in both types. The transcript also mentions the importance of appropriate and inappropriate shocks in this patient population, and the effectiveness of anti-tachycardia pacing (ATP) in terminating ventricular tachycardia. It concludes with recommendations for device selection based on various patient characteristics, and the advantages of subcutaneous defibrillators in terms of lower risk of infection and lead extraction. The performance of subcutaneous ICDs in aborting life-threatening arrhythmias is also mentioned, but specific data on this aspect is not provided.

Meta Tag

Lecture ID 4996

Location Room 152

Presenter Raul Weiss, MD, FHRS

Role Invited Speaker

Session Date and Time May 09, 2019 10:30 AM - 12:00 PM

Session Number S-012

Keywords

hypertrophic myopathy

fibrillators

device selection

subcutaneous defibrillators

ventricular tachycardia